Effects of novel Fufang Biejia Ruangan Tablets with sheep placenta as substitute for Hominis Placenta on CCl(4)-induced liver fibrosis

OBJECTIVE: Fufang Biejia Ruangan Tablet (FBRT) is widely used for the treatment of liver fibrosis. However, Hominis Placenta (HP), as an important adjuvant of FBRT, has been restricted for medicinal using due to the limited availability, ethical controversy and safety issues. The present study aimed...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Baode, Deng, Li, Liu, Yuan, Li, Ruisheng, Shen, Chengying, Liu, Xiao, Li, Yinchao, Yuan, Hailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476806/
https://www.ncbi.nlm.nih.gov/pubmed/36120135
http://dx.doi.org/10.1016/j.chmed.2021.09.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476806/
https://www.ncbi.nlm.nih.gov/pubmed/36120135
http://dx.doi.org/10.1016/j.chmed.2021.09.013

Ejemplares similares